IDNK
IdnK Gluconokinase
Gene Information Card
| Symbol | IDNK |
|---|---|
| Full Name | IdnK Gluconokinase |
| Gene Type | Protein coding |
| Chromosomal Location | 9q21.32 |
| NCBI Gene ID | 445336 ncbi.nlm.nih.gov/gene/445336 |
| Ensembl ID | ENSG00000148090 |
| UniProt ID | Q5T6W2 |
| OMIM ID | 617159 |
| HGNC ID | 28823 |
| Aliases | MGC16169, bA68D7.1 |
Description
IDNK (IdnK Gluconokinase) is a protein-coding gene that encodes an enzyme belonging to the gluconokinase family. This enzyme catalyzes the phosphorylation of D-gluconate to D-gluconate 6-phosphate, a key step in the pentose phosphate pathway (oxidative branch) and in the Entner-Doudoroff pathway. IDNK is involved in carbohydrate metabolism and energy production.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Gluconate kinase deficiency (hypothetical) | Loss of IDNK function impairs gluconate phosphorylation, potentially disrupting pentose phosphate pathway flux and NADPH production. | Inferred from enzymatic function; no direct clinical association reported in OMIM or ClinVar as of 2025. |
| Cancer (general) | Altered gluconate metabolism may affect cellular redox balance and proliferation; IDNK expression changes observed in some tumors. | COSMIC database reports somatic mutations in IDNK across various cancers, but functional significance is not established. |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Liver | 6.8 | Medium |
| Kidney | 5.2 | Medium |
| Heart | 3.1 | Low |
| Brain | 1.5 | Low |
| Testis | 0.9 | Not detected |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HepG2 | 7.2 | Hepatocellular carcinoma cell line |
| HEK293 | 4.5 | Embryonic kidney cells |
| K562 | 2.0 | Chronic myelogenous leukemia |
| A549 | 1.8 | Lung carcinoma |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.1A>G (p.Met1?) | Missense | <0.01% | Likely loss of start codon; predicted loss of function |
| c.347C>T (p.Thr116Met) | Missense | 0.02% | Unknown; benign prediction in ClinVar |
| c.568G>A (p.Glu190Lys) | Missense | 0.01% | Unknown; possibly damaging (in silico) |
Mutation functional classification
Loss of Function (LOF)
Loss-of-function mutations in IDNK are predicted to reduce gluconate kinase activity, potentially impairing gluconate utilization and pentose phosphate pathway flux.
Gain of Function (GOF)
No gain-of-function mutations have been reported for IDNK.
Dominant Negative (DN)
No dominant-negative mutations have been described for IDNK.
View complete mutation data:
Gene Ontology (GO)
| • Gluconokinase activity (GO:0004342) | • ATP binding (GO:0005524) |
| • Phosphorylation (GO:0016310) | • Pentose-phosphate shunt (GO:0006098) |
| • Cytoplasm (GO:0005737) |
Pathways
• Pentose phosphate pathway (oxidative branch)
• Entner-Doudoroff pathway
• Gluconate degradation
Protein Summary
IdnK gluconokinase is a 35.5 kDa enzyme that phosphorylates D-gluconate to D-gluconate 6-phosphate using ATP. It is localized in the cytoplasm and is expressed in tissues with active carbohydrate metabolism, such as liver and kidney. The enzyme plays a role in the pentose phosphate pathway, contributing to NADPH production and ribose-5-phosphate synthesis.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| IDNK Knockout HeLa Cell Line | EDJ-KQ43596 | Human | 414328 | Details Get a Quote |
| IDNK Knockout HCT 116 Cell Line | EDJ-KQ43595 | Human | 414328 | Details Get a Quote |
| IDNK Knockout A-549 Cell Line | EDJ-KQ43594 | Human | 414328 | Details Get a Quote |
| IDNK Knockout HEK293 Cell Line | EDJ-KQ13798 | Human | 414328 | Details Get a Quote |